1 / 17

Glucose and Cholesterol Screening for Pediatric Obesity

Glucose and Cholesterol Screening for Pediatric Obesity. A Training for CHDP Providers Prepared by: The CHDP Nutrition Subcommittee. Goal.

andren
Télécharger la présentation

Glucose and Cholesterol Screening for Pediatric Obesity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glucose and Cholesterol Screening for Pediatric Obesity A Training for CHDP Providers Prepared by: The CHDP Nutrition Subcommittee

  2. Goal • To ensure that children and adolescents with BMI ≥ 85th percentile, as well as those who are at risk but not overweight, are screened for the most common medical conditions associated with childhood overweight

  3. Agenda • Review the medical conditions associated with pediatric overweight/obesity • Summarize the risk factors for complications of pediatric overweight/obesity that need to be identified as part of a health assessment • Clarify the guidelines as described in CHDP Provider Information Notices 05-16 and 05-22

  4. Overweight & Obese ChildrenCalifornia children ages 2 to <5 2009 CDC Pediatric Nutrition Surveillance System growth statistics from CHDP PM160 report

  5. Overweight & Obese ChildrenCalifornia children ages 5 to <20 years 2009 CDC Pediatric Nutrition Surveillance System growth statistics from CHDP PM160 report

  6. Accurate Weight & Stature

  7. BMI BMI Boys: 2 to 20 years BMI BMI BMI Percentile • Select the appropriate growth chart • Record the data • Calculate BMI • Plot measurements • Interpret plotted measurements >99th % Severely obese > 95th % Obese 85th to < 95th % Overweight < 5th % Underweight

  8. Assessment Algorithm In-depth Medical Assessment • Measurements • Weight • Height • Age • Plot Obese Overweight BMI % Growth Chart + Lab Tests (cholesterol & glucose) Normal* Underweight - Note in chart: “Counsel & Follow-up” *Further tests may be warranted depending on family history

  9. Conditions Associated with Childhood Overweight • Orthopedic Conditions • Accelerated Growth • Hip Disorders • Psychological Conditions • Depression/Self-Esteem • Substance Abuse • Disordered Eating • Discrimination • Pulmonary Conditions • Asthma • Sleep Apnea • Cardiovascular Conditions • High Blood Cholesterol • Lipid Disorders • Hypertension (HTN) • Endocrine Conditions • Type 2 Diabetes • Insulin Resistance • Impaired Glucose Tolerance • Menstrual Irregularities • Polycystic Ovarian Syndrome • Gastrointestinal Conditions • Non-Alcoholic Fatty Liver Disease (NAFLD) • Gallstones

  10. Recommended Screening for Children ≥ 5 Years of Age Screen for both cholesterol & glucose* if BMI ≥ 85th % AND two of the following risk factors (may be repeated as medically necessary): • BMI ≥ 95th % • Family history of diabetes • Black, Hispanic, American Indian, Asian, Pacific Islander, Native Alaskan • One of the following: acanthosis nigricans, HTN, dyslipidemia or polycystic ovarian syndrome • Less than 30 minutes activity/day or consistently unbalanced diet *This training is not intended to cover all aspects of type 1 or type 2 diabetes

  11. Recommended Screening for Children ≥ 5 Years of Age Screen for cholesterol if one of the following risk factors is present (may be repeated as medically necessary): • One parent or grandparent had heart/vascular disease, heart attack, heart death, heart surgery or stroke at ≤ 55 years of age* • One parent has a cholesterol level ≥ 240 mg/dl* *Family history may not be available for all children

  12. Referral & Care Managementfor Abnormal Test Results • Fasting glucose ≥ 126 mg/dl (elevated): counsel & repeat test, endocrinology referral and/or CCS referral* • Cholesterol > 170 - < 200 mg/dl (borderline): counsel & repeat test in one year* • Cholesterol ≥ 200 mg/dl (elevated): cardiac referral and/or CCS referral* *Clinical judgment should be used

  13. Screening Guide

  14. Billing Instructions

  15. Laboratories Blood Glucose – Code 25 Cholesterol – Code 26 Use Code 25 and/or 26 ONLY if collecting the sample. Otherwise, denote: “Sent for glucose and/or cholesterol lab.” 25 Blood glucose 26 Blood/Serum Cholesterol Completing the PM160

  16. Resources • For the AMA 2007 Expert Committee Recommendations, go to: www.ama-assn.org/ama/pub/category/11759.html • For the AAP policy on lipid screening and heart health in children, go to: www.aap.org/advocacy/releases/july08lipidscreening.htm • American Diabetes Association: Type 2 Diabetes in Children and Adolescents. Pediatrics 105:671-680, 2000

  17. Summary • Lab screening is necessary to provide quality care for children who are overweight/obese • Glucose and cholesterol screening facilitates early identification of children who are at risk for diabetes and cardiovascular disease • Abnormal lab results can help guide providers to initiate early intervention and/or referral to treatment

More Related